Amalgamated Bank Alkermes Plc. Transaction History
Amalgamated Bank
- $11.7 Billion
- Q1 2025
A detailed history of Amalgamated Bank transactions in Alkermes Plc. stock. As of the latest transaction made, Amalgamated Bank holds 46,320 shares of ALKS stock, worth $1.44 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,320
Previous 47,474
2.43%
Holding current value
$1.44 Million
Previous $1.37 Million
12.01%
% of portfolio
0.01%
Previous 0.01%
Shares
31 transactions
Others Institutions Holding ALKS
# of Institutions
410Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$906 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$567 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$367 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$250 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$214 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.11B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...